Brief: Transcenta Holding Announces IND Clearance From China's NMPA For Tst003
03/01/2023 22:24
Jan 4 (Reuters) - Transcenta Holding Limited 6628.HK :
* IND CLEARANCE FROM CHINA'S NATIONAL MEDICAL PRODUCTS
ADMINISTRATION FOR TST003 FOR TREATMENT OF SOLID TUMORS
Source text for Eikon: ID:
Further company coverage: 6628.HK
Recent news on Transcenta Holding
See all newsBrief: Transcenta Says Global Phase III Trial Of Osemitamab Approved By FDA, China, Korea Regulators
Brief: Transcenta Holding Says Unit To Sell CDMO Assets For RMB190.0 Million
Brief: Transcenta Holding To Revert Assets To Lilly For $4 Million Cash
Brief: Transcenta Therapeutics Appoints Dr. Christopher Hwang As Head Of Global Partnerships For Hicb Platform
Brief: Transcenta Announces Collaboration And Non-Exclusive Licensing Agreement With Eirgenix Inc.